Primo is the street and gym shorthand for Primobolan, a brand name for the anabolic-androgenic steroid methenolone. It comes in two pharmaceutical forms: an oral version (methenolone acetate) and an injectable version (methenolone enanthate). Among bodybuilders it has a reputation as one of the “milder” anabolic steroids, but that label hides real risks to the liver, heart, hormonal balance, and mental health that apply to every anabolic steroid in the class.
The Drug Behind the Nickname
Methenolone is a synthetic derivative of dihydrotestosterone (DHT), modified so that it resists some of the metabolic breakdown that would otherwise inactivate it. The full chemical name of the injectable form is 1-methylandrost-1,4-dien-17β-ol-3-one 17β-heptanoate, but nobody outside a lab uses that. What matters practically is that the two forms behave differently in the body. The oral version, methenolone acetate, has a short-acting ester attached, meaning it clears relatively quickly and needs to be taken more frequently. The injectable version, methenolone enanthate, carries a longer ester chain that creates a slow-release depot in the muscle, keeping blood levels elevated for days after each injection.1Zeitschrift fuer Kristallographie – Crystalline Materials. Exploring the crystal and molecular structures of methenolone and drostanolone enanthate
Like all anabolic-androgenic steroids, methenolone works by binding to androgen receptors in muscle, bone, and other tissues. It is an agonist of the androgen receptor, the same biological target that testosterone and dihydrotestosterone act on.2PubMed Central. Attenuation of Bone Mineral Density Decline During Anemia Treatment With Methenolone Acetate in Myelodysplastic Syndrome Its reputation for mildness comes from the fact that it has a lower androgenic-to-anabolic ratio compared to testosterone itself. In plain terms, the muscle-building signal is relatively stronger, and the masculinizing side effects (deepening voice, body hair growth, acne) are relatively weaker, though “relatively” is doing a lot of heavy lifting in that sentence. Users still experience these effects, especially at higher doses or over longer cycles.
Legitimate Medical Uses, Past and Present
Primobolan was originally developed and marketed as a treatment for muscle-wasting diseases, anemia caused by bone marrow failure, and osteoporosis. In most Western countries, including the United States and across Europe, methenolone is no longer approved or actively used for any of these purposes. Newer, more targeted treatments have replaced it. Japan is a notable exception: methenolone acetate remains approved there for treating anemia due to bone marrow failure, and has been approved for over 50 years for osteoporosis treatment.2PubMed Central. Attenuation of Bone Mineral Density Decline During Anemia Treatment With Methenolone Acetate in Myelodysplastic Syndrome
A 2024 case report documented an interesting secondary benefit in a patient with myelodysplastic syndrome (a bone marrow disorder) who was given methenolone acetate for anemia. Researchers observed that bone mineral density decline was attenuated during treatment, consistent with the drug’s longstanding approval in Japan for osteoporosis.2PubMed Central. Attenuation of Bone Mineral Density Decline During Anemia Treatment With Methenolone Acetate in Myelodysplastic Syndrome This is a niche clinical scenario, though, not an endorsement for widespread use. For the vast majority of people encountering Primo, the context is not a prescription from a hematologist but rather an underground bodybuilding supply chain.
Why Bodybuilders Choose It
In the performance-enhancement world, Primo has a specific niche. Users value it for what they see as a cleaner, more gradual kind of muscle growth compared to heavier-hitting steroids. Because methenolone does not convert (aromatize) into estrogen, users avoid many of the estrogen-related side effects that come with testosterone or other aromatizing steroids, like water retention, bloating, and gynecomastia (breast tissue growth in men). This makes it popular during “cutting” phases, when the goal is to preserve lean muscle while losing body fat, and the bloated look caused by water retention is unwanted.
It also has a reputation for being easier on the liver than most oral steroids. Many oral anabolic steroids are modified at a specific position on their chemical structure (called 17-alpha alkylation) to survive the first pass through the liver, and that modification is what makes them particularly liver-toxic. Methenolone acetate is not 17-alpha alkylated, which is part of why it is considered less hepatotoxic than drugs like oxymetholone or stanozolol. But “less hepatotoxic” should not be confused with “safe.” All anabolic steroids carry liver risk, and oral methenolone is no exception, just lower on the severity spectrum for that particular organ.
The trade-off users consistently report is that Primo’s muscle-building effects are more modest than those of stronger compounds. People who switch to it from something like nandrolone or trenbolone often feel underwhelmed by the gains. This leads many to use it at higher doses than its medical indications ever called for, or to stack it with other steroids, both of which amplify risks.
Cardiovascular and Cholesterol Effects
The most well-documented and arguably most dangerous class of side effects from anabolic steroids involves the cardiovascular system. A literature review of anabolic steroid effects on blood lipids found that these drugs cause dramatic shifts: HDL cholesterol (the “good” kind) dropped by a weighted average of about 52 percent, while LDL cholesterol (the “bad” kind) rose by an average of 36 percent.3PubMed Central. Atherogenic effects of anabolic steroids on serum lipid levels. A literature review Those are not minor fluctuations. That pattern, sustained over months or years of use, accelerates atherosclerosis and raises the risk of heart attack and stroke.
Primo is frequently marketed in gym culture as being “easier on lipids” than oral steroids, and there may be a grain of truth in the idea that non-17-alpha-alkylated compounds disrupt lipid profiles slightly less aggressively. But the general pattern across the steroid class is consistent and severe. Even compounds considered mild still push cholesterol in the wrong direction, particularly at the supraphysiological doses bodybuilders use. The cardiovascular risk from long-term steroid use is not a theoretical future worry; cardiologists who work with steroid users describe premature coronary artery disease in men in their 30s and 40s as a recurring finding.
Liver Risks
Although Primo’s oral form avoids the 17-alpha alkylation that makes many oral steroids especially toxic to the liver, liver damage remains a documented concern across the anabolic steroid class. The forms of liver injury associated with anabolic steroids include cholestasis (a backup of bile flow), peliosis hepatis (blood-filled cysts in the liver), and both benign and malignant liver tumors. Researchers believe the mechanisms behind these problems involve disrupted antioxidant defenses, ramped-up bile acid production, and abnormal growth of liver cells.4PubMed Central. Anabolic androgenic steroid-induced liver injury: An update
Computational pharmacology research has also flagged that many anabolic steroids, including methenolone, can inhibit certain liver enzymes responsible for processing other drugs and foreign chemicals in the body.5PubMed Central / Springer. Computational Assessment of Pharmacokinetics and Biological Effects of Some Anabolic and Androgen Steroids In practical terms, this means steroid users who take other medications or supplements may metabolize them differently, leading to unexpected drug interactions or accumulation of substances the liver would normally clear efficiently.
Tendon and Connective Tissue Problems
This is a risk that catches many users off guard. Anabolic steroids strengthen muscles, but the tendons and connective tissues that anchor those muscles do not always keep pace. In fact, there is evidence that steroids can actively weaken tendons. Animal research found that anabolic steroid treatment reduced the activity of key enzymes involved in collagen production in both muscle and tendons. In Achilles tendons, high-dose steroid treatment led to a measurable decrease in hydroxyproline concentration, a direct marker of collagen content, after three weeks.6PubMed. The effects of anabolic steroids on collagen synthesis in rat skeletal muscle and tendon. A preliminary report
More recent reviews have expanded on this finding, noting that steroid-exposed tendons become stiffer but mechanically weaker, with disordered collagen architecture. The underlying problem appears to be dysregulated turnover of the extracellular matrix, the scaffolding that gives tendons their structure and elasticity.7International Journal of Impotence Research. Health consequences of anabolic steroids: a sexual-medicine perspective The practical consequence is that a steroid user’s muscles may outgrow the capacity of their tendons to support the loads those muscles generate. Tendon ruptures, especially of the biceps and Achilles, are disproportionately common among heavy steroid users. Primo does not get a pass here just because it is considered mild. If you are lifting heavier because the drug is building your muscles faster than your tendons can adapt, the mismatch still applies.
Mental Health and Behavioral Effects
The “roid rage” stereotype is overly simplistic, but it is not entirely wrong. A systematic review and meta-analysis of experimental studies found that anabolic steroid administration increased self-reported aggression in healthy men. The effect was statistically real but small in magnitude.8PubMed Central. Anabolic-androgenic steroid administration increases self-reported aggression in healthy males: a systematic review and meta-analysis of experimental studies What that means is that most users will not suddenly become violent, but there is a measurable nudge toward irritability and aggressive feelings, and in people who already have aggressive tendencies or impulse control problems, that nudge can tip the balance.
Research comparing bodybuilders with and without steroid histories paints a broader picture. Those who had used steroids had more than twice the odds of exhibiting psychopathic traits, roughly three times the odds of engaging in substance-use risk-taking, nearly twice the odds of anger problems, and more than twice the odds of physical health problems compared to non-users.9Scientific Reports. Anabolic–androgenic steroid use is associated with psychopathy, risk-taking, anger, and physical problems It is worth noting that this kind of study cannot prove causation: it is possible that people with these personality profiles are drawn to steroid use rather than being changed by it. But the association is strong enough to warrant caution.
Mood disturbances are another established risk. A controlled study of 160 athletes found that 23 percent of steroid users reported major mood syndromes, including mania, hypomania, or major depression, during periods of steroid use. These mood disorders occurred far more frequently during steroid exposure than during periods when the same individuals were not using, and far more frequently than in non-users.10JAMA Psychiatry. Psychiatric and Medical Effects of Anabolic-Androgenic Steroid Use: A Controlled Study of 160 Athletes That within-person comparison is particularly telling, because it controls for baseline personality. The drugs themselves appear to shift mood.
What Happens When You Stop
One of the least-discussed aspects of steroid use is the crash that follows a cycle. When you flood your body with external androgens, your natural testosterone production shuts down. Once you stop taking the drug, it can take weeks to months for your body’s hormonal axis to restart, and during that window you may experience fatigue, depression, loss of libido, loss of the muscle you gained, and in some cases suicidal thoughts.
This is why post-cycle therapy (PCT) has become standard practice in steroid-using communities. A survey of 470 men who had used anabolic steroids found that about 57 percent reported using some form of PCT when stopping. Those who did reported that PCT reduced their cravings to restart steroids by roughly 60 percent, withdrawal symptoms by about 60 percent, and suicidal thoughts by about 50 percent.11Substance Abuse Treatment, Prevention, and Policy. The use of post-cycle therapy is associated with reduced withdrawal symptoms from anabolic-androgenic steroid use: a survey of 470 men PCT typically involves drugs like clomiphene or tamoxifen that stimulate the body’s own testosterone production, but these are themselves prescription medications with their own side effects and are used off-label in this context.
That nearly half of users in this survey did not use PCT at all is concerning. It suggests a large portion of steroid users are ending cycles without any plan for hormonal recovery, exposing themselves to the full brunt of withdrawal. The fact that suicidal thoughts were reported at all, let alone reportedly reduced by 50 percent with PCT, underscores that this is not a trivial discomfort period.
The Black Market Problem
Because Primo is not legally available by prescription in most countries, virtually all of it comes from underground labs or diverted pharmaceutical supplies. This introduces a problem that sits on top of all the pharmacological risks: you often do not know what you are actually taking. Underground labs operate without regulatory oversight, meaning the powder in a vial labeled “Primobolan” could be methenolone at the stated dose, methenolone at a fraction of the stated dose cut with fillers, a completely different (and often cheaper) steroid substituted in, or contaminated with bacteria, heavy metals, or other manufacturing byproducts.
This is not a paranoid hypothetical. Harm-reduction organizations that test black-market steroids routinely find mislabeled products. A user who thinks they are taking a “mild” cycle of Primo may actually be injecting a different compound entirely, one with a very different risk profile. The gap between what people believe they are putting in their bodies and what they actually are is one of the most underappreciated dangers in the steroid world.
Hormonal Suppression and Fertility
All anabolic steroids suppress the body’s natural production of testosterone through negative feedback on the hypothalamic-pituitary-gonadal axis. When external androgens are present, the brain reduces its signaling to the testes, which in turn shrink and produce less testosterone and fewer sperm. Primo is no exception. Even though it is considered mild in terms of muscle-building potency, it still delivers enough androgenic signaling to suppress natural production.
For men trying to conceive, this is a serious and sometimes lasting problem. Sperm counts can drop to zero during a steroid cycle and may take months, sometimes over a year, to recover after stopping. In some cases, particularly after prolonged use or very high doses, full recovery of fertility never occurs. Computational pharmacological modeling has flagged reproductive dysfunction and endocrine disruption as predicted side effects across the class of anabolic steroids studied, including methenolone.5PubMed Central / Springer. Computational Assessment of Pharmacokinetics and Biological Effects of Some Anabolic and Androgen Steroids
Women who use Primo face a different set of hormonal consequences. Although Primo’s lower androgenic potency makes it one of the steroids occasionally used by women in bodybuilding, virilizing effects, including voice deepening, clitoral enlargement, and increased body hair, can still occur. Some of these changes are irreversible even after the drug is stopped, which is a risk many women underestimate when they hear Primo described as “gentle.”
How It Compares to Other Steroids in the Gym
In the informal hierarchy that bodybuilders use, Primo sits in the “mild but expensive” tier. It is often compared to anavar (oxandrolone), another steroid with a reputation for being relatively gentle, though the two have different chemical structures and somewhat different side-effect profiles. Compared to drugs like trenbolone or nandrolone, Primo produces noticeably less dramatic size and strength gains, which is exactly why users tolerate it: they accept smaller rewards for what they perceive as smaller risks.
That perception is partly right and partly dangerously wrong. It is probably true that a moderate Primo cycle produces fewer acute side effects than an equivalent trenbolone cycle. But the cardiovascular, hormonal, and psychological risks documented across the anabolic steroid class do not disappear because you chose a compound marketed as mild. The cholesterol shifts, the tendon weakening, the hormonal suppression, the mood disturbances: these are class effects. The dose matters, the duration matters, and individual genetics matter, but no compound in this family comes without real costs. The framing of Primo as “the safe steroid” is a marketing narrative created by sellers and repeated by users, not a conclusion supported by the clinical evidence.